THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD)

90 filings reported holding THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share as of Q3 2024.
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 44,027,892 shares of 45,416,671 outstanding shares and own 97% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10,907,859 shares), ORBIMED ADVISORS LLC (5,779,071 shares), BVF INC/IL (4,365,933 shares), EcoR1 Capital, LLC (3,182,444 shares), GENERAL ATLANTIC, L.P. (2,958,762 shares), T. Rowe Price Investment Management, Inc. (2,830,248 shares), TCG Crossover Management, LLC (2,415,000 shares), Boxer Capital, LLC (2,000,000 shares), BlackRock, Inc. (1,458,239 shares), and COMMODORE CAPITAL LP (1,360,569 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.